Clinical Journal of the American Society of Nephrology (CJASN)

Drs. Rhee, Roshanravan, and Nigwekar highlight three cutting-edge dialysis articles on pediatric ESKD iron store biomarkers; HDF, HD, and β-2-microglobulin kinetics; and development of a novel kidney replacement therapy awareness instrument.

Dr. Zhong Zheng provides an overview of his study, "Association of Estimated Glomerular Filtration Rate and Albuminuria with Venous Thromboembolism," on behalf of his colleagues.

Drs. Angela Maria Victoria-Castro and Celia Pamela Corona-Villalobos summarize the findings from their study, "Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project," in Spanish.

Drs. Angela Maria Victoria-Castro and Celia Pamela Corona-Villalobos summarize the findings from their study, "Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project," in English.

Dr. Diana I. Jalal and Colin Gimblet discuss the findings of their study, "Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial," on behalf of their colleagues.

Dr. Arthur M. Lee provides an overview of the results of his study, "Circulating Metabolomic Associations with Neurocognitive Outcomes in Pediatric CKD," on behalf of his colleagues.

Dr. Christine Limonte summarizes the main findings from her study "Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes," on behalf of her colleagues.

Dr. Matthew James, Ellen Novak, and Tayler Scory summarize the results of their study, "Nurse Practitioner Care Compared to Primary Care or Nephrologist Care in Early CKD," on behalf of their colleagues.

Dr. Hattori Koki discusses the results of his study, "Interstitial Eosinophilic Aggregates and Kidney Outcome in Patients with CKD," on behalf of his colleagues.

Drs. Marie-Sophie Meuleman and Sophie Chauvet provide a summary of their study, "Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative Glomerulonephritis," on behalf of their colleagues.

Dr. Reza Malekzadeh gives an overview of the results of his article "Fixed-Dose Combination Therapy for Prevention of Cardiovascular Diseases in CKD: An Individual Participant Data Meta-Analysis," on behalf of his colleagues.

CJASN Editor-in-Chief Rajnish Mehrotra interviews Tristan de Nattes, the 2023 CJASN Trainee of the Year second-place winner, on his article, "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies."

CJASN Editor-in-Chief Rajnish Mehrotra interviews 2023 CJASN Trainee of the Year winner Rosa D. Wouda on her article, "Kaliuresis and Intracellular Uptake of Potassium with Potassium Citrate and Potassium Chloride Supplements."

Drs. Daniel Cattran and Sean Barbour summarize the main results of their study, "Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy," on behalf of their colleagues.

Dr. Rajiv Sinha discusses the findings from his study, "HPA Axis in Single- versus Divided-Dose Prednisolone for First Episode Nephrotic Syndrome: An Open Label RCT," on behalf of his colleagues.

Dr. Morgan Grams provides an overview of the findings of her study, "Discrepancies between Cystatin C–Based and Creatinine-Based Estimated Glomerular Filtration Rates," on behalf of her colleagues.

Drs. Benjamin Adegbite and Evren Azeloglu discuss the results of their study, "Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity," on behalf of their colleagues.

Dr. Farrukh M. Koraishy summarizes the results of his study, "Geographic and Temporal Trends in COVID-Associated Acute Kidney Injury in the National COVID Cohort Collaborative," on behalf of his colleagues.

Dr. Nick Larkins discusses the findings of his study, "Timing of Kidney Replacement Therapy among Children and Young Adults," on behalf of his colleagues.

Dr. Gangadharan Komala provides a summary of the results of his study, "Kidney Adverse Events Associated with Immune Checkpoint Inhibitor Therapy," on behalf of his colleagues.

Mr. Pierre Giguère and Dr. Swapnil Hiremath provide an overview of their study, "Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients," on behalf of their colleagues.

Dr. Gangadharan Komala provides a summary of the results of his study, "Kidney Adverse Events Associated with Immune Checkpoint Inhibitor Therapy," on behalf of his colleagues.

Mr. Pierre Giguère and Dr. Swapnil Hiremath provide an overview of their study, "Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients," on behalf of their colleagues.

Drs. Calyani Ganesan, Alan Pao, and John Leppert discuss the results of their study, "Kidney Stone Events after Kidney Transplant in the United States," on behalf of their colleagues.

Dr. Hiddo J.L. Heerspink summarizes the findings of his study, "Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR," on behalf of his colleagues.

Dr. Hiddo J.L. Heerspink summarizes the findings of his study, "Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR," on behalf of his colleagues.

Drs. Calyani Ganesan, Alan Pao, and John Leppert discuss the results of their study, "Kidney Stone Events after Kidney Transplant in the United States," on behalf of their colleagues.

Drs. Maria de las Mercedes Noriega and Faeq Husain-Syed discuss the results of their study "Kidney Biopsy Findings in Patients with SARS-CoV-2 Infection or After COVID-19 Vaccination," on behalf of their colleagues.

Dr. Dominic Taylor provides a summary of his study "Complex Interventions across Primary and Secondary Care to Optimize Population Kidney Health," on behalf of his colleagues.

Dr. Dominic Taylor provides a summary of his study "Complex Interventions across Primary and Secondary Care to Optimize Population Kidney Health," on behalf of his colleagues.

Drs. Maria de las Mercedes Noriega and Faeq Husain-Syed discuss the results of their study "Kidney Biopsy Findings in Patients with SARS-CoV-2 Infection or After COVID-19 Vaccination," on behalf of their colleagues.

Mr. Jian Roushani and Dr. Peter G. Blake provide an overview of their study "Clinical Outcomes and Vaccine Effectiveness for SARS-CoV-2 Infection in People Attending Advanced CKD Clinics," on behalf of their colleagues.

Dr. Tristan de Nattes discusses the results of his study "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies," on behalf of his colleagues.

Mr. Jian Roushani and Dr. Peter G. Blake provide an overview of their study "Clinical Outcomes and Vaccine Effectiveness for SARS-CoV-2 Infection in People Attending Advanced CKD Clinics," on behalf of their colleagues.

Dr. Tristan de Nattes discusses the results of his study "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies," on behalf of his colleagues.

Drs. Rachel Patzer and Stephen Pastan discuss the results of their study "The ASCENT Intervention to Improve Access and Reduce Racial Inequalities in Kidney Waitlisting," on behalf of their colleagues.

Dr. Casey Rebholz provides a summary of the findings from the study "Metabolomic Markers of Ultra-Processed Food and Incident CKD," on behalf of her colleagues.

Dr. Casey Rebholz provides a summary of the findings from the study "Metabolomic Markers of Ultra-Processed Food and Incident CKD," on behalf of her colleagues.

Drs. Rachel Patzer and Stephen Pastan discuss the results of their study "The ASCENT Intervention to Improve Access and Reduce Racial Inequalities in Kidney Waitlisting," on behalf of their colleagues.

Dr. Kendra Wulczyn discusses the results of her study "Incidence and Risk Factors for Pruritus in Patients with Nondialysis CKD," on behalf of her colleagues.

Dr. Nora Franceschini and Ms. Kaylia Reynolds summarize the findings of their study "Circulating Metabolites Associated with Albuminuria in a Hispanic/Latino Population," on behalf of their colleagues.

Dr. Manish Sood summarizes the findings from his study, "A Health Survey-Based Prediction Equation for Incident CKD," on behalf of his colleagues.

Drs. Fernando Fervenza, Marta Casal Moura, and Ulrich Specks discuss the results of their study, "Maintenance of Remission and Risk of Relapse in Myeloperoxidase Positive Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Renal Involvement."

Dr. Manish Sood summarizes the findings from his study, "A Health Survey-Based Prediction Equation for Incident CKD," on behalf of his colleagues.

Dr. Killian Donovan provides an overview of the conclusions from his study "Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases," on behalf of his colleagues.

CJASN Editor-in-Chief Rajnish Mehrotra interviews Insa Schmidt, the 2022 CJASN Trainee of the Year second-place winner, on her article, "Circulating Plasma Biomarkers in Biopsy-Confirmed Kidney Disease."

CJASN Editor-in-Chief Rajnish Mehrotra interviews 2022 CJASN Trainee of the Year winner Bart J. Kramers on his article, "Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD."